US Patent Issued to ADRENOMED on Aug. 25 for "Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for use in intervention and therapy of congestion in a patient in need thereof" (Dutch Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,911, issued on Aug. 25, was assigned to ADRENOMED AG (Hennigsdorf, Germany).

"Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for use in intervention and therapy of congestion in a patient in need thereof" was invented by Adriaan Voors (Nietap, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Subject matter of the present invention is an anti-Adrenomedullin (ADM) antibody or an anti-Adrenomedullin antibody fragment or an anti-ADM non-Ig scaffold for use in intervention and therapy of congestion in a patient in need thereof."

The patent was filed on June 4, 2021, under Application No. 17/339,221...